NCT06520189View on ClinicalTrials.gov

Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions
Lung Cancer
Interventions
DEVICE

F-18 FDGPET/CT

F-18 FDGPET/CT oncology protocol for lung cancer patients

All Listed Sponsors
lead

Assiut University

OTHER

NCT06520189 - Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer Patients | Biotech Hunter | Biotech Hunter